Flavia A Tejeda-Bayron1, David E Rivera-Aponte1, Christian J Malpica-Nieves1, Gerónimo Maldonado-Martínez2,3, Héctor M Maldonado4, Serguei N Skatchkov5, Misty J Eaton1. 1. Department of Biochemistry, School of Medicine, Universidad Central del Caribe, Bayamón, PR 00960-6032, USA. 2. School of Chiropractic, Universidad Central del Caribe, Bayamón, PR 00960-6032, USA. 3. Biology Department, University of Puerto Rico-Río Piedras Campus, Río Piedras, PR 00924-2537, USA. 4. Department of Pharmacology, School of Medicine, Universidad Central del Caribe, Bayamón, PR 00960-6032, USA. 5. Department of Physiology and Biochemistry, School of Medicine, Universidad Central del Caribe, Bayamón, PR 00960-6032, USA.
Abstract
The authors wish to make the following corrections to this paper [...].
The authors wish to make the following corrections to this paper [...].
The authors wish to make the following corrections to this paper [1]. There are typos in the numbers associated with the compound LDN/OSU 0212320. The numbers were incorrectly typed as LDN/OSU 0232120 in some areas of the manuscript and Supplementary Materials. The correct information is:In the fifth paragraph of Introduction:In 2014, Kong and colleagues characterized a compound, LDN/OSU 0212320 (LDN), that upregulated GLT-1 protein levels at the post-transcriptional level as fast as two hours after injection.In the sub-title of Results:3.1. Effect of LDN/OSU 0212320 Given 24 h before Focal Ischemia on Stroke Outcomes in Male and Female Mice3.2. Effect of LDN/OSU 0212320 Given 2 h after Focal Ischemia on Stroke Outcomes in Male and Female Mice3.3. Effect of LDN/OSU 0212320 on GLT-1 Protein Levels in Brains of Male and Female MiceIn Figure 4 caption:Expression of GLT-1 in brains after a single injection of vehicle or LDN/OSU 0212320 (LDN).In Figure 5 caption:Expression of GLT-1 in female brain cortex after different doses of LDN/OSU 0212320 (LDN).In the Supplementary Materials:The following are available online at www.mdpi.com/2076-3425/11/1/76/s1, Figure S1: Expression of GLT-1 in male brains after a single injection of vehicle or LDN/OSU 0212320 (LDN); Figure S2: Expression of GLT-1 in female brains after a single injection of vehicle or LDN/OSU 0212320 (LDN); Figure S3: Expression of GLT-1 in female brain cortex after different doses of LDN/OSU 0212320 (LDN).In the supplementary file, the figure caption should be:Supplemental Figure S1: Expression of GLT-1 in male brains after a single injection of vehicle or LDN/OSU 0212320 (LDN).Supplemental Figure S2: Expression of GLT-1 in female brains after a single injection of vehicle or LDN/OSU 0212320 (LDN).Supplemental Figure S3: Expression of GLT-1 in female brain cortex after different doses of LDN/OSU 0212320 (LDN).The authors would like to apologize for any inconvenience caused to the readers by these changes.
Authors: Flavia A Tejeda-Bayron; David E Rivera-Aponte; Christian J Malpica-Nieves; Gerónimo Maldonado-Martínez; Héctor M Maldonado; Serguei N Skatchkov; Misty J Eaton Journal: Brain Sci Date: 2021-01-08